Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Central Nervous System Stimulants | 1 | 2023 | 223 | 0.690 |
Why?
|
| Survival Analysis | 1 | 2022 | 1511 | 0.580 |
Why?
|
| Salmonella enterica | 4 | 2015 | 8 | 0.450 |
Why?
|
| HIV Infections | 1 | 2023 | 896 | 0.440 |
Why?
|
| Begomovirus | 1 | 2014 | 1 | 0.440 |
Why?
|
| Insect Control | 1 | 2014 | 4 | 0.440 |
Why?
|
| Hemiptera | 1 | 2014 | 7 | 0.430 |
Why?
|
| Insecticides | 1 | 2014 | 27 | 0.430 |
Why?
|
| Patient Transfer | 2 | 2024 | 103 | 0.400 |
Why?
|
| Prostatic Neoplasms | 4 | 2025 | 1771 | 0.370 |
Why?
|
| Agricultural Irrigation | 4 | 2015 | 4 | 0.370 |
Why?
|
| Fruit | 4 | 2017 | 78 | 0.370 |
Why?
|
| Tumor Hypoxia | 2 | 2022 | 38 | 0.360 |
Why?
|
| Food Contamination | 4 | 2017 | 34 | 0.300 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2025 | 3514 | 0.260 |
Why?
|
| Computer Simulation | 2 | 2022 | 1112 | 0.260 |
Why?
|
| Salmonella | 2 | 2017 | 14 | 0.250 |
Why?
|
| Ponds | 2 | 2015 | 2 | 0.230 |
Why?
|
| Collateral Circulation | 1 | 2025 | 38 | 0.230 |
Why?
|
| Misonidazole | 2 | 2022 | 17 | 0.230 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2025 | 43 | 0.230 |
Why?
|
| Stroke | 2 | 2023 | 1038 | 0.220 |
Why?
|
| Image-Guided Biopsy | 1 | 2025 | 80 | 0.220 |
Why?
|
| Cerebrovascular Circulation | 1 | 2025 | 230 | 0.200 |
Why?
|
| Gender Identity | 1 | 2023 | 54 | 0.200 |
Why?
|
| Emergency Service, Hospital | 2 | 2024 | 555 | 0.200 |
Why?
|
| Time-to-Treatment | 1 | 2024 | 129 | 0.200 |
Why?
|
| Humans | 26 | 2025 | 92340 | 0.200 |
Why?
|
| Rural Population | 1 | 2023 | 151 | 0.200 |
Why?
|
| Ischemic Attack, Transient | 1 | 2023 | 186 | 0.190 |
Why?
|
| Febrile Neutropenia | 1 | 2022 | 16 | 0.190 |
Why?
|
| Male | 14 | 2025 | 43927 | 0.180 |
Why?
|
| Neoplasms | 3 | 2022 | 3124 | 0.180 |
Why?
|
| Zinc | 1 | 2021 | 100 | 0.180 |
Why?
|
| Radiotherapy, Image-Guided | 1 | 2021 | 62 | 0.180 |
Why?
|
| Pneumonia | 1 | 2022 | 187 | 0.170 |
Why?
|
| Probability | 1 | 2022 | 357 | 0.170 |
Why?
|
| Rectum | 1 | 2021 | 148 | 0.170 |
Why?
|
| Brachytherapy | 1 | 2021 | 122 | 0.170 |
Why?
|
| Melanoma | 1 | 2024 | 482 | 0.170 |
Why?
|
| Symptom Assessment | 1 | 2020 | 69 | 0.170 |
Why?
|
| Respiratory Insufficiency | 1 | 2022 | 183 | 0.170 |
Why?
|
| Antibody Formation | 1 | 2020 | 171 | 0.170 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2022 | 295 | 0.160 |
Why?
|
| Triiodothyronine | 1 | 2021 | 359 | 0.160 |
Why?
|
| Dietary Supplements | 2 | 2018 | 126 | 0.160 |
Why?
|
| Immunosuppressive Agents | 1 | 2024 | 989 | 0.160 |
Why?
|
| Mesothelioma | 1 | 2022 | 327 | 0.160 |
Why?
|
| Immunotherapy | 1 | 2024 | 725 | 0.150 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 302 | 0.150 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 471 | 0.150 |
Why?
|
| Oxygen | 2 | 2021 | 763 | 0.150 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2021 | 307 | 0.150 |
Why?
|
| Quercetin | 1 | 2018 | 3 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 2018 | 10 | 0.140 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 1774 | 0.140 |
Why?
|
| Health Personnel | 1 | 2020 | 224 | 0.140 |
Why?
|
| Stomach Neoplasms | 1 | 2021 | 296 | 0.140 |
Why?
|
| Community Health Centers | 1 | 2019 | 116 | 0.140 |
Why?
|
| Female | 11 | 2024 | 47893 | 0.140 |
Why?
|
| Patient Care Team | 1 | 2020 | 296 | 0.140 |
Why?
|
| Digestion | 1 | 2017 | 8 | 0.140 |
Why?
|
| Health Promotion | 1 | 2019 | 168 | 0.140 |
Why?
|
| Animal Feed | 1 | 2017 | 21 | 0.140 |
Why?
|
| Milk | 1 | 2017 | 55 | 0.130 |
Why?
|
| Dietary Fiber | 1 | 2017 | 44 | 0.130 |
Why?
|
| Enzymes | 1 | 2017 | 46 | 0.130 |
Why?
|
| Retrospective Studies | 7 | 2024 | 9689 | 0.130 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 164 | 0.130 |
Why?
|
| Aged | 9 | 2025 | 19951 | 0.130 |
Why?
|
| Referral and Consultation | 1 | 2019 | 352 | 0.120 |
Why?
|
| Prostate | 3 | 2025 | 413 | 0.120 |
Why?
|
| Middle Aged | 10 | 2025 | 27043 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2022 | 1091 | 0.120 |
Why?
|
| Electronic Health Records | 1 | 2019 | 364 | 0.120 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 924 | 0.120 |
Why?
|
| Electron Spin Resonance Spectroscopy | 3 | 2022 | 324 | 0.120 |
Why?
|
| Capsicum | 1 | 2014 | 2 | 0.110 |
Why?
|
| Colitis, Ulcerative | 1 | 2021 | 775 | 0.110 |
Why?
|
| Fertilizers | 1 | 2014 | 9 | 0.110 |
Why?
|
| Vegetables | 1 | 2014 | 47 | 0.110 |
Why?
|
| Salmonella Food Poisoning | 1 | 2013 | 4 | 0.110 |
Why?
|
| Bacteriological Techniques | 1 | 2014 | 40 | 0.110 |
Why?
|
| Nitrogen | 1 | 2014 | 75 | 0.110 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 1191 | 0.110 |
Why?
|
| Potassium | 1 | 2014 | 261 | 0.100 |
Why?
|
| Adult | 5 | 2023 | 27538 | 0.100 |
Why?
|
| Physicians | 1 | 2020 | 693 | 0.100 |
Why?
|
| Hypoxia | 3 | 2022 | 672 | 0.090 |
Why?
|
| Time Factors | 4 | 2024 | 5429 | 0.090 |
Why?
|
| Drug Therapy, Combination | 2 | 2023 | 806 | 0.090 |
Why?
|
| United States | 4 | 2024 | 7348 | 0.080 |
Why?
|
| Positron-Emission Tomography | 2 | 2022 | 342 | 0.080 |
Why?
|
| Registries | 2 | 2024 | 903 | 0.080 |
Why?
|
| Seasons | 3 | 2015 | 241 | 0.080 |
Why?
|
| Animals | 5 | 2025 | 28054 | 0.070 |
Why?
|
| Food Handling | 2 | 2017 | 6 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2025 | 4471 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2024 | 8730 | 0.050 |
Why?
|
| Cerebral Infarction | 1 | 2023 | 73 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2024 | 279 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 6920 | 0.050 |
Why?
|
| Margins of Excision | 1 | 2022 | 42 | 0.050 |
Why?
|
| Aspirin | 1 | 2023 | 163 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2023 | 162 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2022 | 74 | 0.050 |
Why?
|
| Motion | 1 | 2022 | 94 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2025 | 1232 | 0.050 |
Why?
|
| Radiologists | 1 | 2022 | 51 | 0.050 |
Why?
|
| Thrombolytic Therapy | 1 | 2024 | 252 | 0.050 |
Why?
|
| Compliance | 1 | 2021 | 21 | 0.050 |
Why?
|
| Quality of Life | 2 | 2021 | 1745 | 0.050 |
Why?
|
| Cell Hypoxia | 1 | 2022 | 179 | 0.050 |
Why?
|
| Guideline Adherence | 1 | 2023 | 239 | 0.050 |
Why?
|
| Immunity | 1 | 2022 | 149 | 0.050 |
Why?
|
| Acute Disease | 1 | 2023 | 855 | 0.050 |
Why?
|
| Antifungal Agents | 1 | 2022 | 125 | 0.040 |
Why?
|
| Radiopharmaceuticals | 1 | 2022 | 195 | 0.040 |
Why?
|
| Pressure | 1 | 2021 | 169 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2022 | 485 | 0.040 |
Why?
|
| Hormone Replacement Therapy | 1 | 2021 | 93 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2020 | 70 | 0.040 |
Why?
|
| Gastrectomy | 1 | 2021 | 70 | 0.040 |
Why?
|
| Radiotherapy Dosage | 1 | 2021 | 475 | 0.040 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2021 | 85 | 0.040 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2021 | 100 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2022 | 871 | 0.040 |
Why?
|
| Pharmacists | 1 | 2020 | 35 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2022 | 201 | 0.040 |
Why?
|
| Uterus | 1 | 2021 | 222 | 0.040 |
Why?
|
| Contrast Media | 1 | 2025 | 1076 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 127 | 0.040 |
Why?
|
| Genotype | 2 | 2015 | 1865 | 0.040 |
Why?
|
| Nigeria | 1 | 2020 | 160 | 0.040 |
Why?
|
| Hypothyroidism | 1 | 2021 | 264 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2023 | 404 | 0.040 |
Why?
|
| Population Health | 1 | 2019 | 33 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 460 | 0.040 |
Why?
|
| Rats | 1 | 2025 | 4066 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 864 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 2450 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1756 | 0.030 |
Why?
|
| Mice | 2 | 2022 | 12137 | 0.030 |
Why?
|
| Dairying | 1 | 2017 | 3 | 0.030 |
Why?
|
| Endo-1,4-beta Xylanases | 1 | 2017 | 3 | 0.030 |
Why?
|
| Cellulase | 1 | 2017 | 2 | 0.030 |
Why?
|
| Poverty | 1 | 2019 | 189 | 0.030 |
Why?
|
| Milk Proteins | 1 | 2017 | 24 | 0.030 |
Why?
|
| Glycolipids | 1 | 2017 | 30 | 0.030 |
Why?
|
| Lipid Droplets | 1 | 2017 | 19 | 0.030 |
Why?
|
| Lactation | 1 | 2017 | 55 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1901 | 0.030 |
Why?
|
| Humidity | 1 | 2017 | 91 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 1761 | 0.030 |
Why?
|
| Cattle | 1 | 2017 | 381 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 808 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 2035 | 0.030 |
Why?
|
| Eating | 1 | 2017 | 168 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2022 | 1270 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 2793 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2017 | 233 | 0.030 |
Why?
|
| Temperature | 1 | 2017 | 405 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 1920 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2015 | 20 | 0.030 |
Why?
|
| Georgia | 1 | 2015 | 40 | 0.030 |
Why?
|
| Molecular Typing | 1 | 2015 | 17 | 0.030 |
Why?
|
| Florida | 1 | 2015 | 60 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 902 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2015 | 77 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2015 | 150 | 0.030 |
Why?
|
| Chicago | 1 | 2019 | 1463 | 0.030 |
Why?
|
| Culture Media | 1 | 2014 | 149 | 0.030 |
Why?
|
| Food Microbiology | 1 | 2013 | 9 | 0.030 |
Why?
|
| Patient Selection | 1 | 2018 | 690 | 0.030 |
Why?
|
| Diet | 1 | 2017 | 448 | 0.030 |
Why?
|
| Bacterial Typing Techniques | 1 | 2013 | 28 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 1805 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2013 | 196 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 2685 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 923 | 0.020 |
Why?
|
| Risk Factors | 1 | 2022 | 5706 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 1847 | 0.020 |
Why?
|
| Child | 1 | 2022 | 7309 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 2009 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 808 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 6630 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 9495 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2015 | 1392 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1724 | 0.020 |
Why?
|